Annual Current Liabilities
$6.15 M
+$409.00 K+7.13%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual total current liabilities is $6.15 million, with the most recent change of +$409.00 thousand (+7.13%) on December 31, 2023.
- During the last 3 years, TARA annual current liabilities has risen by +$3.23 million (+110.94%).
- TARA annual current liabilities is now at all-time high.
Performance
TARA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$8.64 M
+$2.99 M+53.01%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly total current liabilities is $8.64 million, with the most recent change of +$2.99 million (+53.01%) on September 30, 2024.
- Over the past year, TARA quarterly current liabilities has increased by +$1.87 million (+27.56%).
- TARA quarterly current liabilities is now at all-time high.
Performance
TARA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TARA Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.1% | +27.6% |
3 y3 years | +110.9% | +27.6% |
5 y5 years | +99.8% | +27.6% |
TARA Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +43.1% | at high | +202.1% |
5 y | 5-year | at high | +110.9% | at high | +202.1% |
alltime | all time | at high | +110.9% | at high | +1069.4% |
Protara Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $8.64 M(+53.0%) |
Jun 2024 | - | $5.65 M(+2.7%) |
Mar 2024 | - | $5.50 M(-10.5%) |
Dec 2023 | $6.15 M(+7.1%) | $6.15 M(-9.2%) |
Sep 2023 | - | $6.78 M(+37.4%) |
Jun 2023 | - | $4.93 M(-23.1%) |
Mar 2023 | - | $6.41 M(+11.7%) |
Dec 2022 | $5.74 M(+33.6%) | $5.74 M(+54.7%) |
Sep 2022 | - | $3.71 M(+6.2%) |
Jun 2022 | - | $3.49 M(+22.1%) |
Mar 2022 | - | $2.86 M(-33.4%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $4.30 M(+47.4%) | $4.30 M(+16.5%) |
Sep 2021 | - | $3.69 M(+0.5%) |
Jun 2021 | - | $3.67 M(+10.7%) |
Mar 2021 | - | $3.31 M(+13.7%) |
Dec 2020 | $2.92 M(-13.0%) | $2.92 M(-25.0%) |
Sep 2020 | - | $3.89 M(+12.8%) |
Jun 2020 | - | $3.45 M(-30.6%) |
Mar 2020 | - | $4.97 M(+48.2%) |
Dec 2019 | $3.35 M(+8.9%) | $3.35 M(+353.5%) |
Sep 2019 | - | $739.00 K |
Dec 2018 | $3.08 M | - |
FAQ
- What is Protara Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Protara Therapeutics?
- What is Protara Therapeutics annual current liabilities year-on-year change?
- What is Protara Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Protara Therapeutics?
- What is Protara Therapeutics quarterly current liabilities year-on-year change?
What is Protara Therapeutics annual total current liabilities?
The current annual current liabilities of TARA is $6.15 M
What is the all time high annual current liabilities for Protara Therapeutics?
Protara Therapeutics all-time high annual total current liabilities is $6.15 M
What is Protara Therapeutics annual current liabilities year-on-year change?
Over the past year, TARA annual total current liabilities has changed by +$409.00 K (+7.13%)
What is Protara Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TARA is $8.64 M
What is the all time high quarterly current liabilities for Protara Therapeutics?
Protara Therapeutics all-time high quarterly total current liabilities is $8.64 M
What is Protara Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TARA quarterly total current liabilities has changed by +$1.87 M (+27.56%)